Literature DB >> 8595908

Localization of the human achaete-scute homolog gene (ASCL1) distal to phenylalanine hydroxylase (PAH) and proximal to tumor rejection antigen (TRA1) on chromosome 12q22-q23.

B Renault1, J Lieman, D Ward, K Krauter, R Kucherlapati.   

Abstract

ASCL1, the human achaete-scute homolog, is a helix-loop-helix transcription factor that was previously assigned to chromosome 12 using a rodent-human somatic hybrid panel. We now placed this gene on a yeast artificial chromosome contig encompassing position 119 cM of the Généthon genetic map between the two genes phenylalanine hydroxylase (PAH) and tumor rejection antigen 1 (TRA1). We also localized ASCL1 in the 12q22-q23 cytogenetic interval by using fluorescence in situ hybridization.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8595908     DOI： 10.1006/geno.1995.0012

Source DB:  PubMed          Journal:  Genomics        ISSN： 0888-7543            Impact factor:   5.736


  3 in total

1.  Retroviral insertions in Evi12, a novel common virus integration site upstream of Tra1/Grp94, frequently coincide with insertions in the gene encoding the peripheral cannabinoid receptor Cnr2.

Authors:  P J Valk; Y Vankan; M Joosten; N A Jenkins; N G Copeland; B Löwenberg; R Delwel
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  Genetic association analyses of PHOX2B and ASCL1 in neuropsychiatric disorders: evidence for association of ASCL1 with Parkinson's disease.

Authors:  Masayuki Ide; Kazuo Yamada; Tomoko Toyota; Yoshimi Iwayama; Yuichi Ishitsuka; Yoshio Minabe; Kazuhiko Nakamura; Nobutaka Hattori; Takashi Asada; Yoshikuni Mizuno; Norio Mori; Takeo Yoshikawa
Journal:  Hum Genet       Date:  2005-07-14       Impact factor: 4.132

3.  [Expression and clinicopathologic significance of human achaete-scute homolog 1 in pulmonary neuroendocrine tumors].

Authors:  Fei Li; Zhiyong Zhong; Rui Li; Heyu Huang; Lijun Wang; Donghan Zheng; Daorong Zhang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2010-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.